björn_witte Blue Horizon

Bjöern Witte © Blue Horizon

Interviews

Blue Horizon: “The Wave of Innovation That Will Be Rolling Towards Us in the Coming Years is Huge”

Bjoern Witte, Managing Partner and CEO of Blue Horizon, gives his insights into the world of alternative protein investments, the company’s plans for 2023, and his thoughts as to the future of the category. What does your current portfolio look like; in which new companies did you invest in 2022? We see a lot of very innovative companies that we source through our Seed portfolio which sort of acts like our finger on the pulse of the industry. One example of a new company we invested in this year would be Arkeon, an Austrian company that produces proteins from carbon dioxide. Arkeon’s technology makes it possible to convert CO2 directly into all 20 amino acids that are essential for human nutrition. At the same time, …

more

Stray Dog Capital

Johnny Ream. © Stray Dog Capital

Interviews

Stray Dog Capital: “Our Portfolio Companies Produce 98% Fewer Farm Emissions Compared to the Meat Industry”

Stray Dog Capital is a venture capital fund with a focus on companies making the food system more ethical and sustainable. The fund’s impressive portfolio spans plant-based, cultivated, and precision fermentation companies, including notable names such as Miyoko’s Creamery, Good Catch, and Aleph Farms. As a frontrunner in alt protein and biotech investments, Stray Dog recognises that it is becoming ever more challenging to make investment decisions, as these sectors continue to rapidly expand. Partner Johnny Ream spoke to us about how the fund will respond to the increased competition and what the future holds. Tell us about your investment approach at Stray Dog Capital. At Stray Dog Capital, we focus on investing in innovative, early-stage companies across the food and beverage and biotechnology sectors …

more

TheUntappedClimateOp_report Blue Horizon

© Blue Horizon

People

Bjoern Witte on Latest Blue Horizon Report: “The Positive Impact is Absolutely Massive”

The second part of the latest research from Blue Horizon and BCG, following the first instalment last month, finds that consumers are embracing alternative proteins and that protein transformation is one of the best tools available to combat the climate crisis. The study, titled ‘The Untapped Climate Opportunity In Alternative Proteins’, finds that almost a third of consumers would switch their diets to alternative proteins if doing so would have a major positive impact on climate change.  Food for Thought Report co-author Bjoern Witte, Managing Partner and CEO of Blue Horizon, here offers his commentary on the report. “Globally, there has been an increase in the number of people buying alternative proteins. In our first Food for Thought report in 2021 we predicted that alternative …

more

björn_witte Blue Horizon

Bjöern Witte © Blue Horizon

Interviews

Blue Horizon: “One of the Clear Leaders in Sustainable Food Investing”

Björn Witte is Managing Partner and CEO of Blue Horizon Corporation.  He was also a Co-Founder and acted as CEO of the LIVEKINDLY Collective. Björn talks to vegconomist about the future of protein and how Blue Horizon is on track to reach the 1 billion dollar mark in funding this year. Where does Blue Horizon currently stand, in terms of funding and number of investments etc? We had an intensive start to the new year. Especially in our seed portfolio we have been very active and have made some extremely exciting new seed investments. One of them, for example, is Arkeon, an Austrian company that produces proteins from carbon dioxide. Arkeon’s technology makes it possible to convert CO2 directly into all 20 amino acids that …

more